Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAStem for Severe COVID-19
NCT04331613Phase 2Unknown
- Sponsor
- Chinese Academy of Sciences
- Start
- Jan 2020
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CAStem cells in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by Chinese Academy of Sciences. Status: unknown.
02
Drugs
CAStem cells
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04331613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04331613.